Alignment Healthcare 3Q 2026: Revenue $1.36B, Net loss $8.1M, EPS $(0.04) — 10-Q Summary

Alignment Healthcare reported 3Q 2026 revenue of $1.36B, up 36.7% YoY, driven by 31.2% membership growth. Net loss was $8.1M, compared to a $3.7M profit in the prior-year quarter. The company cited higher medical costs and plans to expand markets and invest in technology.

Original reporting
Published Oct 29, 2026, 8:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Alignment Healthcare 3Q 2026: Revenue $1.36B, Net loss $8.1M, EPS $(0.04) — 10-Q Summary — source image
Decision brief

The 30-second read

$ALHCBearishMed
01

Why it matters

The earnings release shows a mixed picture: robust revenue growth but a swing to loss, suggesting short‑term pressure but potential upside from market expansion.

02

Market read

The earnings surprise is the primary driver for the stock’s near‑term movement; sector peers may be re‑priced based on cost‑structure concerns.

03

What to watch

The 3.5‑star rating for the California H3815 contract and continued market expansion may support longer‑term upside.

Relevance 7/10Novelty 7/10Timing: post-market release

Background

Alignment Healthcare is a publicly traded health‑plan operator that recently expanded into five states and reported a significant membership increase.

Company-level read

Ticker impact

$ALHCBearishHigh confidence
Context

Alignment Healthcare posted Q3 2026 results with revenue up 36.7% YoY to $1.36B but a net loss of $8.1M, reversing prior-year profit.

Expected impact

likely downside as market prices in the unexpected loss and higher costs

Evidence & confidence

The company’s loss contrasts with prior-year profit and higher expenses, which typically depresses the stock on earnings day.

Market effects

Highlights cost pressure in the health‑plan sector, may affect peers with similar cost structures.

U.S. health‑plan stocks could see modest volatility following the report.

Limited to U.S. healthcare investors; no broader macro impact.

Counterpoint

If the market overreacts to the loss, the stock could rebound on the strong membership growth and revenue expansion.

Key entities

  • Alignment Healthcare, Inc.

    U.S. health‑plan operator reporting Q3 2026 results.

Related articles

$ALHCMedAI 8/10

Alignment Healthcare (ALHC) Q3 2026 Earnings Call Transcript

Alignment Healthcare (ALHC) reported Q3 2026 earnings, with revenue of $1.4B (up 37% YoY) and adjusted gross profit of $142M. The company lowered annual guidance due to higher costs, targeting adjusted gross profit of at least $575M and adjusted EBITDA of $100M. Membership grew 31% YoY to 301,200. ALHC is addressing cost pressures and investing in clinical programs for 2027 growth.

$ALHCMedAI 8/10

What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call

Alignment Healthcare (ALHC) reduced its 2026 outlook, expecting at least $5.25B revenue, $575M adjusted gross profit, and $100M adjusted EBITDA. Q4 forecasts include 305K membership, $1.32B revenue, and $104M gross profit. Management targets 20% top-line growth in 2027, with plans to enter new markets and improve care model scalability. Stars ratings and provider alignment remain focus areas.